We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$517B
AUM Growth
+$27.6B
Cap. Flow
-$8.37B
Cap. Flow %
-1.62%
Top 10 Hldgs %
19.4%
Holding
4,590
New
277
Increased
1,772
Reduced
2,129
Closed
201

Top Sells

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$692M
2
LIN icon
Linde
LIN
+$624M
3
MDT icon
Medtronic
MDT
+$527M
4
GS icon
Goldman Sachs
GS
+$340M
5
MSFT icon
Microsoft
MSFT
+$301M

Sector Composition

Rank Sector Weight
1 Technology 25.11%
2 Healthcare 13.18%
3 Financials 12.45%
4 Consumer Discretionary 10.8%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOWL icon
3776
Werewolf Therapeutics
HOWL
$18.8M
$387K ﹤0.01%
+22,213
New +$304K
FSTX
3777
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$387K ﹤0.01%
+45,062
New +$384K
PLBC icon
3778
Plumas Bancorp
PLBC
$442M
$384K ﹤0.01%
12,005
-12,580
-51% -$367K
FBND icon
3779
Fidelity Total Bond ETF
FBND
$27.4B
$380K ﹤0.01%
7,138
-1,979
-22% -$105K
SRT
3780
DELISTED
Startek Inc.
SRT
$380K ﹤0.01%
53,307
-348
-0.6% -$2.56K
SLYG icon
3781
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.23B
$378K ﹤0.01%
4,259
+450
+12% +$39.2K
FSK icon
3782
FS KKR Capital
FSK
$3.49B
$377K ﹤0.01%
17,488
+7,018
+67% +$150K
VYGR icon
3783
Voyager Therapeutics
VYGR
$198M
$377K ﹤0.01%
91,256
-85,334
-48% -$387K
ALPN
3784
DELISTED
Alpine Immune Sciences Inc
ALPN
$377K ﹤0.01%
41,862
+19,178
+85% +$208K
NAZ icon
3785
Nuveen Arizona Quality Municipal Income Fund
NAZ
$159M
$376K ﹤0.01%
+23,230
New +$364K
KLDO
3786
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$376K ﹤0.01%
50,528
+5,069
+11% +$35.9K
IYG icon
3787
iShares US Financial Services ETF
IYG
$2.24B
$374K ﹤0.01%
6,075
+2,277
+60% +$139K
ELMD icon
3788
Electromed
ELMD
$352M
$373K ﹤0.01%
32,998
-14,770
-31% -$151K
SDG icon
3789
iShares MSCI Global Sustainable Development Goals ETF
SDG
$175M
$373K ﹤0.01%
3,756
+970
+35% +$94.5K
CBFV icon
3790
CB Financial Services
CBFV
$190M
$371K ﹤0.01%
16,744
-14,373
-46% -$313K
IOO icon
3791
iShares Global 100 ETF
IOO
$9.46B
$371K ﹤0.01%
5,229
+387
+8% +$27K
SNDA icon
3792
Sonida Senior Living
SNDA
$1.88B
$371K ﹤0.01%
+7,485
New +$333K
EEMS icon
3793
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$378M
$370K ﹤0.01%
5,911
-546
-8% -$33K
BCYC
3794
Bicycle Therapeutics
BCYC
$279M
$368K ﹤0.01%
12,120
-30
-0.2% -$906
RQI icon
3795
Cohen & Steers Quality Income Realty Fund
RQI
$1.69B
$368K ﹤0.01%
23,414
+6,680
+40% +$101K
CMF icon
3796
iShares California Muni Bond ETF
CMF
$4.63B
$364K ﹤0.01%
+5,813
New +$363K
CRBP icon
3797
Corbus Pharmaceuticals
CRBP
$195M
$361K ﹤0.01%
6,574
-2,330
-26% -$129K
OVID icon
3798
Ovid Therapeutics
OVID
$523M
$359K ﹤0.01%
91,847
-59,183
-39% -$234K
MT icon
3799
ArcelorMittal
MT
$55.2B
$357K ﹤0.01%
11,467
+1,873
+20% +$58K
BPRN icon
3800
Princeton Bancorp
BPRN
$296M
$355K ﹤0.01%
12,384
-15,713
-56% -$452K

Similar funds

Bank of New York Mellon's Q2 2021 Portfolio in Review

As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
  • Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
  • Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
  • Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
  • Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
  • Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
  • Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.